|
LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women—Prospective substudy of the randomized multicenter LION study. |
|
|
Stock and Other Ownership Interests - Theraclion |
Honoraria - FBI; Gyn Update; Med Publico; MedConcept; Medicultus Kassel; Medupdate; Pfizer; Pierre Fabre; Roche Pharma AG |
Consulting or Advisory Role - Pharma Marathi; Roche Pharma AG; Tesaro |
Research Funding - Celgene (Inst) |
|
|
Honoraria - AstraZeneca; Pharma Marathi; Roche; Tesaro |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novolink Pharmaceutical; Roche; Tesaro |
Research Funding - Amgen (Inst); DAYER (Inst); Lilly (Inst); Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche (Inst) |
|
|
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva |
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro |
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro |
|
|
Honoraria - Abbott; Cepheid; Hologic; Roche; Vaccibody |
Research Funding - Vaccibody (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - PharmaMar; Tesaro |
Consulting or Advisory Role - Advaxis; AstraZeneca; Genmab; Pfizer; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Pharma Marathi |
|
|
Honoraria - Janssen Diagnostics |
Research Funding - Janssen Diagnostics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |